Drug profile · INN
benralizumab
FASENRA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
benralizumab (FASENRA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN benralizumab
Brand FASENRA
Route INJECTION
Formulation INJECTABLE
ATC code R03DX10
Frequently asked questions
What is benralizumab?
benralizumab (FASENRA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for benralizumab?
FASENRA is a marketed brand name for benralizumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of benralizumab?
benralizumab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.